businessmen talking at conference table

Our senior leaders bring a powerful combination of proven commercial, strategic and scientific capabilities

Our Executive Team

Thomas McCourt

Thomas McCourt

Chief Executive Officer
Michael Shetzline, M.D., Ph.D

Michael Shetzline, M.D., Ph.D.

SVP, Chief Medical Officer and Head of Research and Development
Susanna Y. Huh, MD, MPH

Susanna Y. Huh, MD, MPH

Vice President and Head of Clinical Development

Sravan K. Emany

Chief Financial Officer
Diane Stroehmann

Diane Stroehmann

Vice President, Regulatory Affairs and Global Patient Safety

John Minardo

Senior Vice President, Chief Legal Officer

Tammi Gaskins

Vice President of Brand Management

Andrew Davis

Senior Vice President, Chief Business Officer

Beth Calitri

Head of Corporate Communications and Media Relations
Mike Nanfito

Mike Nanfito

Vice President of Sales and Sales Excellence

Jana Noeldeke

Basel Site Head & Apraglutide Lifecycle Leader

Our highly experienced and diverse board is instrumental in creating shareholder value

Our Board of Directors

Julie McHugh

Chair, Biopharmaceutical Industry Executive, Retired

Mark Currie, Ph.D.

Partner, Iaso Ventures, LP

Alexander Denner, Ph.D.

Founding Partner and Chief Investment Officer, Sarissa Capital Management LP

Andrew Dreyfus

Former President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts

Jon Duane

McKinsey & Company, Retired

Marla Kessler

Former Chief Marketing Officer, Datavant, Inc.

Thomas McCourt

Chief Executive Officer, Ironwood Pharmaceuticals

Catherine Moukheibir

Former Chief Executive Officer, MedDay Pharmaceuticals

Jay P. Shepard

Former President and CEO of Aravive, Inc.
Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here